Juvenile toxicity of cyclosporin in the rat

Linda Allais1, Fabienne Condevaux, Pierluigi Fant

  • 1MDS Pharma Services, 329 Impasse du Domaine Rozier, Les Oncins, 69210 Saint-Germain sur l'Arbresle, France. linda.allais@mdsinc.com

Insights

Cyclosporin exposure in young rats impaired immune responses and caused toxicity at higher doses. Adverse immune effects were only observed when systemic toxicity was also present.

Area of Science:

  • Immunotoxicology
  • Developmental Toxicology
  • Pharmacology

Background:

  • Cyclosporin is an immunosuppressive drug with potential developmental toxicity.
  • Understanding the dose-dependent effects of cyclosporin on developing immune systems is crucial.

Purpose of the Study:

  • To evaluate the impact of early-life cyclosporin exposure on immune system development and systemic toxicity in Sprague-Dawley rats.

Main Methods:

  • Rat pups (32 litters) received oral cyclosporin (0, 1, 3, or 10 mg/kg/day) from postnatal days 4-28.
  • Primary antibody response was assessed at 10 weeks of age.
  • Systemic toxicity, weight gain, and histopathology (heart, kidney) were evaluated.

Main Results:

  • A dose of 10 mg/kg/day caused persistent impairment of the primary antibody response.
  • Systemic toxicity, including pup mortality and reduced weight gain, occurred at 10 mg/kg/day.
  • Cardiovascular arteriopathy and kidney lesions (tubular basophilia, edema) were observed at 3 and 10 mg/kg/day.

Conclusions:

  • Pharmacological effects of cyclosporin were observed across all tested doses.
  • Adverse effects on immune system development were evident only at the highest dose, which also induced systemic toxicity.

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...